Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Breast Cancer × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 9 Neoplasms 6 Lung Neoplasms 5 Colorectal Neoplasms 4 Breast Neoplasms, Male 4 Neoplasm Metastasis 3 Melanoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Ovarian Neoplasms 2 Inflammatory Breast Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pancreatic Ductal Adenocarcinoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasms, Glandular and Epithelial 1 Neoplasms, Basal Cell 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Mouth Neoplasms 1

Interventions

sacituzumab govitecan 1 eribulin 1 balixafortide 1 Taxes 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡